Evaluation of Diagnostic Modalities for SARS-Cov-۲: A Review Study

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 246

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJER-8-3_008

تاریخ نمایه سازی: 1 آبان 1400

Abstract:

Background and aims: In late December ۲۰۱۹, a cluster of progressive pneumonia-like respiratory syndromes broke out in Wuhan, China. As the number of cases continued to rise, the ۲۰۱۹ coronavirus disease (COVID-۱۹) has been declared a global public health emergency. The causative agent, i.e., SARS-CoV-۲, is a highly contagious strain, which has resulted in the rapid worldwide outbreak of COVID-۱۹. COVID-۱۹ is an overwhelmingly transmissible disease that requires early and accurate diagnosis for proper and timely treatment of suspected cases. Materials and Methods: In order to access the scientific documentation and evidence related to the subject published during ۲۰۱۹ to ۲۰۲۱, English keywords including “COVID-۱۹”, “SARS-CoV-۲”, “Diagnosis”, “Immunoglobulin G (IgG)”, “Immunoglobulin M (IgM)”, and ‘Polymerase Chain Reaction (PCR)” were searched in Medline, PubMed, and Google Scholar databases and Persian versions of these keywords were also looked for in Jihad-e Daneshgahi’s Scientific Information Database (SID) and Iranian Journals database (Magiran) Results: With respect to diagnosis, serum antibody assays, nucleic acid sequencing, and radiologic evaluation are among the most reliable methods to rule out the disease in suspicious cases. This review is a synopsis of the pathogenesis of coronavirus, which will mainly focus on the diagnostic methods, as well as laboratory changes in immunoglobulins, polymerase chain reaction results, and computed tomography (CT) findings. Conclusion: Early diagnosis matters in that it not only contributes to the prevention of further transmission of the virus by asymptomatic carriers but also paves the way for clinicians to accurately choose the best therapeutic approach depending on the status of the patients.

Keywords:

Authors

Roghayeh Sheervalilou

Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Jamal Ahmadzadeh

Epidemiologist, Social Determinants of Health Research Center, Urmia University of Medical Sciences, Urmia, Iran

Sahel Alavi

School of Nursing, Gerash University of Medical Sciences, Gerash, Iran

Kazhal Mobaraki

Epidemiologist, Social Determinants of Health Research Center, Urmia University of Medical Sciences, Urmia, Iran

Saman Sargazi

Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran

Milad Shirvaliloo

Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Ali Golchin

Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Ali Yekanlou

Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Sahar Mehranfar

Department of Genetics and Immunology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :